Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Watson

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Health Promotion International|January 17, 2025
Patient safety is our business! Staff perspectives on implementing hospital falls prevention educationCheng Yen Loo, Steffanie Coulter, Carol Watson, et al.
Western Journal of Nursing Research|February 13, 2025
Health Professional Perceptions of Delivering Hospital Falls Prevention Education-A Qualitative StudyAnne-Marie Hill, Cheng Yen Loo, Steffanie Coulter, et al.
Molecular and Cellular Biology|June 3, 2010
Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cellsJaclyn S Long, Joanne Edwards, Carol Watson, et al.
The American Journal of Pathology|October 5, 2010
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patientsCarol Watson, Jaclyn S Long, Clare Orange, et al.
Emergency Medicine Australasia : EMA|October 14, 2025
Variable Adherence to Australian Clinical Care Standard: An Audit of Patients With Acute Low Back Pain Attending a Tertiary Emergency DepartmentJane Males, Leigh Hobday, Michelle Hobday, et al.
Plos One|January 30, 2026
Evaluating the effect of the SMART intervention in people with recently diagnosed breast cancer who are being treated at a public tertiary hospital in Australia: protocol and statistical analysis plan for a single-blinded, single centre randomised controlled trialSusan Stinton, Dale Edwick, Chloe Maxwell-Smith, et al.
Western Journal of Nursing Research|June 24, 2026
Engaging With Hospital Staff to Develop Implementation Strategies For Delivering a Patient Falls Prevention Education Program Using a World CaféCheng Yen Loo, Meg E Morris, Jacqueline Francis-Coad, et al.
Journal of Medicinal Chemistry|June 17, 2014
Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agentsWu Yang, Yufeng Wang, Amy Lai, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 7, 2024
Informing the management of the post-COVID condition: insights from the Western Australian experience comparing those who tested positive and negative to early COVID-19 strainsKristen Grove, Vinicius Cavalheri, HuiJun Chih, et al.
Journal of Medicinal Chemistry|June 28, 2019
Discovery of Potent Protease-Activated Receptor 4 Antagonists with in Vivo Antithrombotic EfficacyMichael M Miller, Jacques Banville, Todd J Friends, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Health Promotion International|January 17, 2025
Patient safety is our business! Staff perspectives on implementing hospital falls prevention educationCheng Yen Loo, Steffanie Coulter, Carol Watson, et al.
Western Journal of Nursing Research|February 13, 2025
Health Professional Perceptions of Delivering Hospital Falls Prevention Education-A Qualitative StudyAnne-Marie Hill, Cheng Yen Loo, Steffanie Coulter, et al.
Molecular and Cellular Biology|June 3, 2010
Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cellsJaclyn S Long, Joanne Edwards, Carol Watson, et al.
The American Journal of Pathology|October 5, 2010
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patientsCarol Watson, Jaclyn S Long, Clare Orange, et al.
Emergency Medicine Australasia : EMA|October 14, 2025
Variable Adherence to Australian Clinical Care Standard: An Audit of Patients With Acute Low Back Pain Attending a Tertiary Emergency DepartmentJane Males, Leigh Hobday, Michelle Hobday, et al.
Plos One|January 30, 2026
Evaluating the effect of the SMART intervention in people with recently diagnosed breast cancer who are being treated at a public tertiary hospital in Australia: protocol and statistical analysis plan for a single-blinded, single centre randomised controlled trialSusan Stinton, Dale Edwick, Chloe Maxwell-Smith, et al.
Western Journal of Nursing Research|June 24, 2026
Engaging With Hospital Staff to Develop Implementation Strategies For Delivering a Patient Falls Prevention Education Program Using a World CaféCheng Yen Loo, Meg E Morris, Jacqueline Francis-Coad, et al.
Journal of Medicinal Chemistry|June 17, 2014
Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agentsWu Yang, Yufeng Wang, Amy Lai, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 7, 2024
Informing the management of the post-COVID condition: insights from the Western Australian experience comparing those who tested positive and negative to early COVID-19 strainsKristen Grove, Vinicius Cavalheri, HuiJun Chih, et al.
Journal of Medicinal Chemistry|June 28, 2019
Discovery of Potent Protease-Activated Receptor 4 Antagonists with in Vivo Antithrombotic EfficacyMichael M Miller, Jacques Banville, Todd J Friends, et al.
Pageof 4